Keyphrases
Age Groups
50%
Airflow
16%
Airway
50%
Airway Function
16%
Asthma Exacerbation
16%
Asthmatic children
50%
Asymptomatic Infection
16%
Baseline Characteristics
8%
Benzodiazepines
33%
Carbon Tetrachloride
16%
CCL20
25%
CCL24
25%
CCL5
16%
Children with Asthma
50%
Copy number
16%
Credible Interval
8%
CXCL10
25%
Efficacy Outcomes
16%
Established Status Epilepticus
50%
Forced Expiratory Flow
16%
Forced Expiratory Volume in 1 Second (FEV1)
16%
Fosphenytoin
50%
Fractional Exhaled Nitric Oxide (FeNO)
16%
IL-4/IL-13
16%
Illness
25%
Inflammation
16%
Levetiracetam
50%
Lung Function
50%
Melanoma Differentiation-associated Gene 5 (MDA5)
16%
Nasal
33%
Nasal Lavage
16%
New-onset Refractory Status Epilepticus (NORSE)
16%
Older Adults
33%
Primary Safety
16%
Pulmonary Volume
16%
Randomized Controlled Trial
50%
Respiratory Illness
33%
Respiratory Viral Infection
58%
Response-adaptive
16%
Rhinovirus
16%
Safety Outcomes
33%
Status Epilepticus Treatment
50%
Surveillance Samples
16%
Symptom Score
33%
Treatment Trials
50%
Upper Respiratory Tract
16%
Urban children
50%
Valproate
50%
Viral Infection
58%
Virus
58%
Medicine and Dentistry
Absence
7%
Adaptive Response
14%
Airflow
7%
Apoplexy
7%
Arrhythmia
7%
Aspiration
7%
Asthma
50%
Asthma Exacerbation
7%
Asymptomatic Disease
7%
Benzodiazepine
28%
Biological Marker
28%
Chemokine
21%
Common Cold
7%
Common Cold Symptom
7%
Disease
21%
Drug Infusion
7%
Drug Therapy
7%
Emergency Department
14%
Epileptic Seizure
7%
Forced Expiratory Flow
14%
Fosphenytoin
50%
Hypotension
7%
Infection
7%
Intention-to-Treat Analysis
7%
Interferon Induced Helicase C Domain Containing Protein 1
7%
Levetiracetam
50%
Lung Volume
14%
Neurologic Disease
7%
Nitric Oxide
14%
Nucleic Acid
7%
Pathophysiology
7%
Pharmacodynamics
7%
Randomized Controlled Trial
50%
Respiratory Disease
14%
Respiratory Tract Inflammation
7%
Rhinovirus
14%
Sodium Valproate
50%
Spirometry
7%
Status Epilepticus
50%
Subclinical Infection
7%
Symptom
50%
Tonic-Clonic Seizure
7%
Tracheal Intubation
7%
Upper Respiratory Tract
7%
Viral Respiratory Tract Infection
50%
Viral Upper Respiratory Tract Infection
7%
Immunology and Microbiology
Airflow
26%
Asthma
57%
Asthma Exacerbation
19%
CCL20
26%
CCL24
26%
CCL5
14%
Chemokine
37%
CXCL10
26%
Cytokine
50%
Exhaled Nitric Oxide
25%
Forced Expiratory Flow
25%
Inflammation Response
7%
Interleukin 13
14%
Lung Volume
25%
MDA5
7%
Proinflammatory Cytokine
7%
Rhinovirus
25%
Upper Respiratory Tract
25%
Viral Disease
100%